A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Jeffrey L. Silber, Jason M. Norman, Tokuwa Kanno, Emily M. Crossette, Rose Szabady, Rajita Menon, Melissa Marko, Ling-Yang Hao, Lynn Tomsho, Sunita Bhagat, Anna Yuan, Bernat Olle, Esi Lamousé-Smith
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417035348